G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $121,943,000 | -6.4% | 9,087 | +34.8% | 0.03% | -3.3% |
| Q2 2021 | $130,301,000 | -11.4% | 6,741 | +10.3% | 0.03% | -28.6% |
| Q1 2021 | $147,000,000 | +32.9% | 6,110 | -0.7% | 0.04% | +27.3% |
| Q4 2020 | $110,633,000 | +64.3% | 6,150 | +5.5% | 0.03% | +65.0% |
| Q3 2020 | $67,333,000 | -51.9% | 5,830 | +1.1% | 0.02% | -45.9% |
| Q2 2020 | $139,898,000 | +121.3% | 5,767 | +0.5% | 0.04% | +105.6% |
| Q1 2020 | $63,230,000 | – | 5,738 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |